Trademark: 85151406
Status Date
Friday, February 9, 2018
Registration Number
3988925
Registration Date
Tuesday, July 5, 2011
Filing Date
Wednesday, October 13, 2010
Published for Opposition
Tuesday, April 19, 2011
Cancellation Date
Friday, February 9, 2018
5 Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain cancers and blood diseases and printed dosage instructional manuals sold together as a unit
Feb 9, 2018
Cancelled Sec. 8 (6-Yr)
Jul 5, 2016
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 30, 2015
Teas Change Of Correspondence Received
Jul 5, 2011
Registered-Principal Register
Apr 19, 2011
Official Gazette Publication Confirmation E-Mailed
Apr 19, 2011
Published For Opposition
Mar 11, 2011
Law Office Publication Review Completed
Mar 8, 2011
Approved For Pub - Principal Register
Mar 8, 2011
Examiner's Amendment Entered
Mar 8, 2011
Notification Of Examiners Amendment E-Mailed
Mar 8, 2011
Examiners Amendment E-Mailed
Mar 8, 2011
Examiners Amendment -Written
Mar 8, 2011
Teas/Email Correspondence Entered
Mar 8, 2011
Correspondence Received In Law Office
Feb 28, 2011
Assigned To Lie
Feb 23, 2011
Teas Request For Reconsideration Received
Feb 22, 2011
Notification Of Final Refusal Emailed
Feb 22, 2011
Final Refusal E-Mailed
Feb 22, 2011
Final Refusal Written
Jan 28, 2011
Teas/Email Correspondence Entered
Jan 28, 2011
Correspondence Received In Law Office
Jan 19, 2011
Assigned To Lie
Jan 14, 2011
Assigned To Lie
Dec 31, 2010
Teas Response To Office Action Received
Dec 30, 2010
Notification Of Non-Final Action E-Mailed
Dec 30, 2010
Non-Final Action E-Mailed
Dec 30, 2010
Non-Final Action Written
Dec 23, 2010
Assigned To Examiner
Oct 19, 2010
Teas Amendment Entered Before Attorney Assigned
Oct 19, 2010
Teas Voluntary Amendment Received
Oct 19, 2010
New Application Office Supplied Data Entered In Tram
Oct 16, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
